The invention relates to N-methylpyrrolidone and N,N-dimethylacetamide solvates of cefprozil. The invention also relates to processes for preparing the solvates of cefprozil, crystalline cefprozil from said solvates and pharmaceutical compositions that include the crystalline cefprozil.
